M&A Opportunity Invina Healthcare Technologies acquired MAK-SYSTEM in July 2026, indicating potential for existing customers and contracts to transition under new ownership. This signals a ready path for cross-sell or upsell of extended blood management and end-to-end data integration solutions to InVita’s global network.

Strategic Partnerships Past and ongoing partnerships with blood banks and transfusion services such as Northern Ireland Blood Transfusion Service and NYBCe suggest a continued need for scalable software to manage vein-to-vein workflows, donor management, and regulatory compliance across regulated environments.

Cloud and DataCapability Recognition of cloud platform launches with AWS and the use of PostgreSQL and Salesforce indicate a strong foundation for cloud-native, secure, and compliant blood biologics management solutions. This creates sales opportunities around cloud migration, data analytics, and interoperability with existing healthcare IT stacks.

Regulatory Focus Industry emphasis on regulated environments and advanced therapies (tissue, gene, cell) points to demand for configurable, compliant software capable of supporting complex workflows, traceability, and quality management across global sites, ideal for upsell with governance modules.

Financial Scale With revenue in the mid tens of millions and a customer footprint that includes major international blood centers, there is opportunity to target mid-market portfolios with expanded modules, managed services, and long-term maintenance contracts to drive higher lifecycle value.